HHS Q2 2025 Earnings Narrower Loss and Modest Stock Gain Amid Sparse Disclosures ORMP Q4 2025 Earnings Surprise Profit Beats Zero Estimate as Biotech Advances Pipeline NPCE Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Surprise MHH Q1 2026 Earnings EPS Miss Disappoints Despite Positive Stock Movement MBINL Q1 2026 Earnings Preferred Shares Beat EPS Estimates on Strong Core Performance PRU Q1 2026 Earnings Strong EPS Beat Drives Positive Sentiment Despite Modest Stock Dip AREC Q3 2025 Earnings NarrowerthanExpected Loss Drives Positive Sentiment SANUWAVE Health Inc Q1 2026 Earnings Significant EPS Miss Leads to Stock Decline FITBI Q1 2026 Earnings Strong EPS Beat Highlights Resilient Core Operations Cameco Q1 2026 Earnings EPS Falls Short Amid Market Headwinds ATRA Q1 2026 Earnings Narrowed Loss Beats Estimates as Clinical Progress Continues Dermata Therapeutics DRMA Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Continues Pipeline Progress